Annual Cash & Cash Equivalents
$4.60 M
-$2.90 M-38.67%
December 1, 2023
Summary
- As of February 7, 2025, ADXN annual cash & cash equivalents is $4.60 million, with the most recent change of -$2.90 million (-38.67%) on December 1, 2023.
- During the last 3 years, ADXN annual cash & cash equivalents has fallen by -$16.80 million (-78.49%).
- ADXN annual cash & cash equivalents is now -96.28% below its all-time high of $123.57 million, reached on December 31, 2007.
Performance
ADXN Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$3.98 M
-$232.50 K-5.52%
September 1, 2024
Summary
- As of February 7, 2025, ADXN quarterly cash and cash equivalents is $3.98 million, with the most recent change of -$232.50 thousand (-5.52%) on September 1, 2024.
- Over the past year, ADXN quarterly cash and cash equivalents has dropped by -$1.22 million (-23.38%).
- ADXN quarterly cash and cash equivalents is now -94.62% below its all-time high of $73.93 million, reached on December 31, 2009.
Performance
ADXN Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
ADXN Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -38.7% | -23.4% |
| 3 y3 years | -78.5% | -82.2% |
| 5 y5 years | -89.1% | - |
ADXN Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -79.5% | at low | -82.2% | +120.7% |
| 5 y | 5-year | -85.9% | at low | -87.8% | +120.7% |
| alltime | all time | -96.3% | +230.6% | -94.6% | +186.0% |
Addex Therapeutics Ltd Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $3.98 M(-5.5%) |
| Jun 2024 | - | $4.21 M(+133.6%) |
| Mar 2024 | - | $1.80 M(-60.8%) |
| Dec 2023 | $4.60 M(-38.7%) | $4.60 M(-11.4%) |
| Sep 2023 | - | $5.20 M(-34.8%) |
| Jun 2023 | - | $7.97 M(+30.2%) |
| Mar 2023 | - | $6.12 M(-18.4%) |
| Dec 2022 | $7.50 M(-66.5%) | $7.50 M(-29.8%) |
| Sep 2022 | - | $10.69 M(+15.7%) |
| Jun 2022 | - | $9.23 M(-42.7%) |
| Mar 2022 | - | $16.13 M(-28.0%) |
| Dec 2021 | $22.41 M(+4.7%) | $22.41 M(+35.2%) |
| Sep 2021 | - | $16.57 M(-15.7%) |
| Jun 2021 | - | $19.66 M(-26.6%) |
| Mar 2021 | - | $26.77 M(+25.1%) |
| Dec 2020 | $21.40 M(-34.3%) | $21.40 M(+10.5%) |
| Sep 2020 | - | $19.37 M(-10.9%) |
| Jun 2020 | - | $21.73 M(-23.1%) |
| Mar 2020 | - | $28.25 M(-13.2%) |
| Dec 2019 | $32.55 M(-23.1%) | $32.55 M(-13.5%) |
| Jun 2019 | - | $37.62 M(-11.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2018 | $42.32 M(+1498.4%) | $42.32 M(-3.1%) |
| Jun 2018 | - | $43.67 M(+1549.4%) |
| Dec 2017 | $2.65 M(+90.2%) | $2.65 M(-29.2%) |
| Jun 2017 | - | $3.74 M(+168.7%) |
| Dec 2016 | $1.39 M(-47.8%) | $1.39 M(-39.5%) |
| Jun 2016 | - | $2.30 M(-13.6%) |
| Dec 2015 | $2.66 M(+33.1%) | $2.66 M(-31.0%) |
| Jun 2015 | - | $3.86 M(+93.0%) |
| Dec 2014 | $2.00 M(-39.0%) | $2.00 M(-14.8%) |
| Jun 2014 | - | $2.35 M(-28.4%) |
| Dec 2013 | $3.28 M(-80.4%) | $3.28 M(-30.7%) |
| Jun 2013 | - | $4.74 M(-71.6%) |
| Dec 2012 | $16.71 M(-56.4%) | $16.71 M(-20.3%) |
| Jun 2012 | - | $20.96 M(-45.3%) |
| Dec 2011 | $38.34 M(-43.8%) | $38.34 M(-36.4%) |
| Jun 2011 | - | $60.28 M(-11.7%) |
| Dec 2010 | $68.25 M(-7.7%) | $68.25 M(+29.8%) |
| Jun 2010 | - | $52.58 M(-28.9%) |
| Dec 2009 | $73.93 M(-33.9%) | $73.93 M |
| Dec 2008 | $111.79 M(-9.5%) | - |
| Dec 2007 | $123.57 M(+268.2%) | - |
| Dec 2006 | $33.56 M | - |
FAQ
- What is Addex Therapeutics Ltd annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Addex Therapeutics Ltd?
- What is Addex Therapeutics Ltd annual cash & cash equivalents year-on-year change?
- What is Addex Therapeutics Ltd quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Addex Therapeutics Ltd?
- What is Addex Therapeutics Ltd quarterly cash and cash equivalents year-on-year change?
What is Addex Therapeutics Ltd annual cash & cash equivalents?
The current annual cash & cash equivalents of ADXN is $4.60 M
What is the all time high annual cash & cash equivalents for Addex Therapeutics Ltd?
Addex Therapeutics Ltd all-time high annual cash & cash equivalents is $123.57 M
What is Addex Therapeutics Ltd annual cash & cash equivalents year-on-year change?
Over the past year, ADXN annual cash & cash equivalents has changed by -$2.90 M (-38.67%)
What is Addex Therapeutics Ltd quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of ADXN is $3.98 M
What is the all time high quarterly cash and cash equivalents for Addex Therapeutics Ltd?
Addex Therapeutics Ltd all-time high quarterly cash and cash equivalents is $73.93 M
What is Addex Therapeutics Ltd quarterly cash and cash equivalents year-on-year change?
Over the past year, ADXN quarterly cash and cash equivalents has changed by -$1.22 M (-23.38%)